Aug 3, 2026 04:05PM
Aug 3, 2026 04:01PM
Jul 13, 2026 07:42AM
Jul 6, 2026 04:14PM
Jul 6, 2026 04:04PM
Jul 6, 2026 04:04PM
Jul 1, 2026 07:58PM FDA expands Casgevy approval to children as young as 2
Jul 1, 2026 07:58PM
Jul 1, 2026 05:43PM
Jun 11, 2026 02:01AM
Jun 5, 2026 12:05PM
Jun 5, 2026 12:00PM
Jun 1, 2026 08:01AM
Jun 1, 2026 08:00AM Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy
May 6, 2026 07:01AM
May 6, 2026 07:01AM
May 5, 2026 07:50AM
May 4, 2026 04:01PM
Apr 19, 2026 10:00AM
Apr 1, 2026 07:31AM
Apr 1, 2026 07:30AM Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
Mar 10, 2026 09:51AM
Mar 9, 2026 04:02PM
Mar 9, 2026 04:02PM
Mar 5, 2026 10:00AM
Mar 5, 2026 10:00AM
Feb 12, 2026 04:01PM
Jan 23, 2026 12:56PM Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
Jan 23, 2026 04:44AM
Jan 12, 2026 04:07AM
Jan 11, 2026 05:00PM
Dec 16, 2025 12:00PM
Dec 8, 2025 02:54AM
Dec 6, 2025 07:01AM
Nov 8, 2025 05:15PM Vertex reports promising phase 1/2 data for povetacicept kidney drug
Nov 8, 2025 05:15PM
Nov 3, 2025 04:02PM
Oct 23, 2025 09:01AM
Oct 23, 2025 09:00AM
Oct 17, 2025 09:04AM
Oct 17, 2025 09:04AM
Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
Oct 1, 2025 01:13PM
Sep 25, 2025 07:45AM
Sep 25, 2025 07:45AM
Sep 23, 2025 09:00AM
Sep 11, 2025 09:05AM
Aug 6, 2025 06:51AM
Aug 5, 2025 09:34AM Vertex (VRTX) PT Lowered to $530 at BMO Capital
Aug 5, 2025 09:28AM

327,806 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All